Vee M-26 en es it fr

Vee M-26 Brand names, Vee M-26 Analogs

Vee M-26 Brand Names Mixture

  • No information avaliable

Vee M-26 Chemical_Formula

C32H32O13S

Vee M-26 RX_link

http://www.rxlist.com/cgi/generic2/teniposide.htm

Vee M-26 fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=110

Vee M-26 msds (material safety sheet)

Vee M-26 Synthesis Reference

No information avaliable

Vee M-26 Molecular Weight

656.655 g/mol

Vee M-26 Melting Point

No information avaliable

Vee M-26 H2O Solubility

No information avaliable

Vee M-26 State

Solid

Vee M-26 LogP

1.963

Vee M-26 Dosage Forms

Liquid

Vee M-26 Indication

Treatment of refractory acute lymphoblastic leukaemia

Vee M-26 Pharmacology

Teniposide is a phase-specific cytotoxic drug, acting in the late S or early G 2 phase of the cell cycle, thus preventing cells from entering mitosis. Teniposide causes dose-dependent single- and double-stranded breaks in DNA and DNA: protein cross-links. The mechanism of action appears to be related to the inhibition of type II topoisomerase activity since teniposide does not intercalate into DNA or bind strongly to DNA.

Vee M-26 Absorption

No information avaliable

Vee M-26 side effects and Toxicity

No information avaliable

Vee M-26 Patient Information

No information avaliable

Vee M-26 Organisms Affected

Humans and other mammals